STADA Philippines shows resilience with triple-digit growth in 2020

Newly - established pharmaceutical play-er STADA Philippines showed resilience amid the coronavirus pandemic by achieving triple digit sales growth of 478% in 2020.

Peter Goldschmidt – CEO , STADA

Fueling the growth is the expansion of the STADA Philippines portfolio, with the banner acquisition of the FERN-C line (consisting of the established, 15-year-old vitamin c brand FERN-C, and two children’s vitamin products – FERN C Kidz and Kiddimin). Total sales growth of the Fern-C portfolio in 2020 reached 100% compared to the previous year.

STADA Philippines’ revitalization of the Oilatum brand, likewise, established the company as a major player the Philippine skin care market, with Oilatum sales growing 1012% versus the previous year. Acquired from GSK in 2019, Oilatum is a full emollient range that generates significant sales in Europe, as well as helping to build up growth in the Asia Pacific region.

The acquisition of these products is in line with our strategy of strengthening our portfolio with well-established consumer healthcare brands and also expanding in selected emerging markets, states Carsten Cron, STADA EVP for Emerging Markets.

Sharmaine Abarientos, General Manager of STADA Philippines, adds: “With our successful portfolio expansion activities, we are able to offer quality medicines at reasonable prices, across all segments of healthcare; specialty, generics and consumer health.”

Sharmaine Abarientos – General Manager, STADA Philippines

PH performance mirrors STADA Worldwide’s strong growth journey